Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients von Bohula, Erin A, Wiviott, Stephen D, McGuire, Darren K, Inzucchi, Silvio E, Kuder, Julia, Im, KyungAh, Fanola, Christina L, Qamar, Arman, Brown, Conville, Budaj, Andrzej, Garcia-Castillo, Armando, Gupta, Milan, Leiter, Lawrence A, Weissman, Neil J, White, Harvey D, Patel, Tushar, Francis, Bruce, Miao, Wenfeng, Perdomo, Carlos, Dhadda, Shobha, Bonaca, Marc P, Ruff, Christian T, Keech, Anthony C, Smith, Steven R, Sabatine, Marc S, Scirica, Benjamin M

Volltext

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody von Swanson, Chad J, Zhang, Yong, Dhadda, Shobha, Wang, Jinping, Kaplow, June, Lai, Robert Y K, Lannfelt, Lars, Bradley, Heather, Rabe, Martin, Koyama, Akihiko, Reyderman, Larisa, Berry, Donald A, Berry, Scott, Gordon, Robert, Kramer, Lynn D, Cummings, Jeffrey L

Volltext

Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 pro... von McDade, Eric, Cummings, Jeffrey L, Dhadda, Shobha, Swanson, Chad J, Reyderman, Larisa, Kanekiyo, Michio, Koyama, Akihiko, Irizarry, Michael, Kramer, Lynn D, Bateman, Randall J

Volltext

The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease von Rafii, Michael S., Sperling, Reisa A., Donohue, Michael C., Zhou, Jin, Roberts, Claire, Irizarry, Michael C., Dhadda, Shobha, Sethuraman, Gopalan, Kramer, Lynn D, Swanson, Chad J, Li, David, Krause, Stephen, Rissman, Robert A., Walter, Sarah, Raman, Rema, Johnson, Keith A., Aisen, Paul S.

Volltext

Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study von Murphy, Patricia, Moline, Margaret, Mayleben, David, Rosenberg, Russell, Zammit, Gary, Pinner, Kate, Dhadda, Shobha, Hong, Quan, Giorgi, Luigi, Satlin, Andrew

Volltext

ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease von Honig, Lawrence S., Barakos, Jerome, Dhadda, Shobha, Kanekiyo, Michio, Reyderman, Larisa, Irizarry, Michael, Kramer, Lynn D., Swanson, Chad J., Sabbagh, Marwan

Volltext

ASP2151 for the Treatment of Genital Herpes: A Randomized, Double-Blind, Placebo- and Valacyclovir-Controlled, Dose-Finding Study von Tyring, Stephen, Wald, Anna, Zadeikis, Neddie, Dhadda, Shobha, Takenouchi, Kazumasa, Rorig, Ramona

Volltext

Updated safety results from phase 3 lecanemab study in early Alzheimer's disease von Honig, Lawrence S, Sabbagh, Marwan N, van Dyck, Christopher H, Sperling, Reisa A, Hersch, Steven, Matta, Andre, Giorgi, Luigi, Gee, Michelle, Kanekiyo, Michio, Li, David, Purcell, Derk, Dhadda, Shobha, Irizarry, Michael, Kramer, Lynn

Volltext

Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease von Dhadda, Shobha, Kanekiyo, Michio, Li, David, Swanson, Chad J, Irizarry, Michael, Berry, Scott, Kramer, Lynn D, Berry, Donald A

Volltext

Fully automated and highly specific plasma β-amyloid immunoassays predict β-amyloid status defined by amyloid positron emission tomography with high accuracy von Yamashita, Kazuto, Miura, Masahiro, Watanabe, Shunsuke, Ishiki, Kengo, Arimatsu, Yuji, Kawahira, Junko, Kubo, Toshiko, Sasaki, Katsutaka, Arai, Takayuki, Hagino, Kei, Irino, Yasuhiro, Nagai, Kota, Verbel, David, Koyama, Akihiko, Dhadda, Shobha, Niiro, Hayato, Iwanaga, Shigeki, Sato, Toshiyuki, Yoshida, Tomokazu, Iwata, Atsushi

Volltext

Plasma pTau181 enhances the prediction of future clinical decline in amyloid‐positive mild cognitive impairment von Devanarayan, Viswanath, Llano, Daniel A., Hu, Yan Helen, Hampel, Harald, Kramer, Lynn, Dhadda, Shobha, Irizarry, Michael

Volltext

Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer's disease von Honig, Lawrence S, Sabbagh, Marwan N, van Dyck, Christopher H, Sperling, Reisa A, Hersch, Steven, Matta, Andre, Giorgi, Luigi, Gee, Michelle, Kanekiyo, Michio, Li, David, Purcell, Derk, Dhadda, Shobha, Irizarry, Michael, Kramer, Lynn

Volltext

Design of a Bayesian adaptive phase 2 proof-of-concept trial for BAN2401, a putative disease-modifying monoclonal antibody for the treatment of Alzheimer's disease von Satlin, Andrew, Wang, Jinping, Logovinsky, Veronika, Berry, Scott, Swanson, Chad, Dhadda, Shobha, Berry, Donald A

Volltext

Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery von BARTON, Scott F, LANGELAND, Fred F, SNABES, Michael C, LECOMTE, Diane, KUSS, Michael E, DHADDA, Shobha S, HUBBARD, Richard C

Volltext

Decision making in clinical trials: Interim analyses, innovative design, and biomarkers von Welsh‐Bohmer, Kathleen A., Kerchner, Geoffrey A., Dhadda, Shobha, Garcia, Miguel, Miller, David S., Natanegara, Fanni, Raket, Lars Lau, Robieson, Weining, Siemers, Eric R., Carrillo, Maria C., Weber, Christopher J.

Volltext

Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody von Swanson, Chad J, Zhang, Yong, Dhadda, Shobha, Wang, Jinping, Kaplow, June, Lai, Robert Y K, Lannfelt, Lars, Bradley, Heather, Rabe, Martin, Koyama, Akihiko, Reyderman, Larisa, Berry, Donald A, Berry, Scott, Gordon, Robert, Kramer, Lynn D, Cummings, Jeffrey L

Volltext

Lecanemab in Early Alzheimer’s Disease von van Dyck, Christopher H., Swanson, Chad J., Aisen, Paul, Bateman, Randall J., Chen, Christopher, Gee, Michelle, Kanekiyo, Michio, Li, David, Reyderman, Larisa, Cohen, Sharon, Froelich, Lutz, Katayama, Sadao, Sabbagh, Marwan, Vellas, Bruno, Watson, David, Dhadda, Shobha, Irizarry, Michael, Kramer, Lynn D., Iwatsubo, Takeshi

Volltext

Once-daily tacrolimus extended release formulation : Experience at 2 years postconversion from a prograf-based regimen in stable liver transplant recipients von FLORMAN, Sander, ALLOWAY, Rita, DHADDA, Shobha, WISEMANDLE, Kathleen, WIRTH, Mary, FITZSIMMONS, William, HOLMAN, John, FIRST, M. Roy, KALAYOGLU, Munci, PUNCH, Jeffrey, BAK, Thomas, MELANCON, Joseph, KLINTMALM, Goran, BUSQUE, Stephan, CHARLTON, Michael, LAKE, John

Volltext

Impact of Clinical Subgroup and Baseline Amyloid PET Centiloid Levels on Occurrence of ARIA in the Lecanemab Phase 3 Clarity AD Study in Early Alzheimer’s Disease (P1-9.007) von Sabbagh, Marwan, Li, David, Dhadda, Shobha, Hersch, Steven, Giorgi, Luigi, Matta, Andre, Irizarry, Michael, Kramer, Lynn

Volltext

Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial von Rosenberg, Russell, Murphy, Patricia, Zammit, Gary, Mayleben, David, Kumar, Dinesh, Dhadda, Shobha, Filippov, Gleb, LoPresti, Antonia, Moline, Margaret

Volltext